Baron & Budd Attorney and Shareholder Burton LeBlanc to Speak on Opioid Epidemic at American Association for Justice
BATON ROUGE, La. – November 17, 2017 – The national law firm of Baron & Budd is pleased to...READ MORE
The U.S. Food and Drug Administration (FDA) has announced an investigation into whether the drug Stalevo, which is used to treat Parkinson’s disease, may increase elderly patients’ risk of heart attack and stroke. The FDA encourages patients taking the drug to talk to their physicians about their risk of cardiovascular disease.
For the full story, go to the Los Angeles Times.